Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Baylor College of Medicine, Berry Genomics Co. Seek to Improve on Prenatal Genetic Tests

Published: Monday, January 07, 2013
Last Updated: Monday, January 07, 2013
Bookmark and Share
Teams aim to improve prenatal genetic testing by combining BCM’s expertise in using microarrays for DNA analysis and Berry’s non-invasive technology evaluating fetal DNA in maternal plasma.

BCM’s highly ranked genetics program, led by National Academy of Sciences member Dr. Arthur Beaudet, has been dedicated to providing the medical community with high-quality and comprehensive genetics testing services for over 30 years. BCM’s Medical Genetics Lab has pioneered the development and use of microarray technology for the testing of prenatal/pediatric genetic disorders for more than 50,000 cases.

The microarray testing uses a gene-chip to assess the make-up of chromosomes (organized structures of DNA and proteins that are found in cells) in a particular part of the human genome (genetic blue print). In areas of the genome, there are portions of the genetic material that show imbalances because they are duplicated or deleted abnormally with gains and losses of genetic information that may signal risk for a genetic disorder.

Berry Genomics has developed technologies to screen and test for genetic abnormalities of the fetus by evaluating fetal DNA in maternal plasma. This technology avoids invasive prenatal diagnostic procedures of chorionic villus sampling, which requires samples being taken from the placenta, and/or amniocentesis, where samples are taken from the amniotic sac around the developing fetus.

These procedures have been a source of anxiety and apprehension for expectant mothers, Beaudet said.

"We are committed to improving the diagnostic sensitivity of invasive prenatal testing as exemplified by our participation in a recently published collaborative National Institutes of Health-funded study," said Dr. Arthur Beaudet, chair and professor of molecular and human genetics at BCM. "We are conducting research to enable non-invasive prenatal testing to detect all the conditions currently detected by invasive testing. It is an honor and a privilege to participate in this international collaboration."

"We are very pleased to enter this agreement with Baylor College of Medicine," said Dr. Daixing Zhou, CEO of Berry Genomics. "Non-invasive prenatal testing and microarray technology are rapidly changing the way we detect genetic diseases. By collaborating with Baylor College of Medicine, we are now able to offer the complete solutions for prenatal screening and diagnosis."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Largest Genomic Study on Kidney Cancer
Understanding the complexity of cancer is a major goal of the scientific community, and for kidney cancer researchers this goal just got closer.
Wednesday, March 16, 2016
Baylor, DNAnexus Collaborate
Partnership sets out to develop HgV, a new iteration of HGSC's Mercury, a BCM-developed data processing and variant calling pipeline for analyzing and annotating next-generation sequencing data in research and clinical contexts.
Tuesday, June 23, 2015
$3M NIH Grant Enables Baylor International HIV/AIDS Program
Researchers to study genetic differences of disease in sub-Saharan African children.
Wednesday, February 19, 2014
Scientific News
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
Heart Defect Prediction Technology Could Lead to Earlier, More Informed Treatment
Experimental method uses genetics-guided biomechanics, patient-specific stem cells.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
Big Data Can Save Lives
The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen's University Belfast.
Fast, Simple Test for Colitis
A minimally invasive screening for ulcerative colitis using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body.
Scans Reveal Babies of Mothers with Gestational Diabetes Have More Body Fat
Researchers at Imperial College London have found that the babies born to mothers with gestational diabetes have more body fat at two months of age compared to babies born to healthy mothers.
New Device Could Improve Cancer Detection
UBC researchers develop a microfluidic device to capture circulating tumor cells.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
Newborn Screening Test Developed For Rare, Deadly Neurological Disorder
Scientists have developed a new dried blood spot screening test for Niemann-Pick type C, with goal to speed diagnosis and treatment.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!